Familial Chylomicronemia Syndrome | FCS Treatment Options
Familial Chylomicronemia Syndrome
Home
About FCS
Signs and Symptoms
Diet Considerations
Non-Dietary
Treatment Options
Resources

Non-Dietary Treatment Options

Treatment of Patients with FCS
There is currently no pharmacotherapy approved in the United States to treat patients with FCS.

Though there is anecdotal evidence that some patients MAY benefit from approved triglyceride lowering medications [fibrates, niacin (nicotinic acid) or statins (HMG-CoA reductase inhibitors)], FCS experts believe that strict adherence to a low fat diet is the only effective way to manage FCS.4

Plasmapheresis (removal, cleaning, and reinsertion of patient’s blood/plasma) may be necessary for some patients.

The possibility of gene therapy for FCS is currently being explored.

Why Lipid Lowering Agents Are Ineffective
Management of FCS is a
Team Effort
Content funded by Novartis Pharmaceuticals Corporation and developed in collaboration with Rare Disease Report. All material on this website protected by copyright, Copyright 2014 Rare Disease Report.
About RareDR
Terms and Conditions
RareDR
HCPLive®